Colgate-Palmolive Co. (CL)
Colgate-Palmolive Company (CL) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Colgate-Palmolive Company (CL) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Colgate-Palmolive: Wide Moat And A Mispriced Future
Colgate-Palmolive (CL)'s diverse category system creates a deeper moat than its simple products suggest. It shows how shared chemistry, manufacturing flexibility and retail presence strengthen its competitive position. Hill's provides a stabilising demand pattern that supports the broader portfolio especially during slowdowns.
Colgate-Palmolive: This Dividend King Is Rebounding (Technical Analysis)
Colgate-Palmolive (CL) is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2022 Global Productivity Initiative and renewed focus on growth businesses. Technical analysis shows institutional accumulation, with positive momentum signals and a breakout above resistance on strong volume.
Is Colgate's Innovation Engine Enough to Revive Its Volumes?
CL bets on faster, science-led innovation and a global Colgate Total relaunch to overcome soft volumes and regain momentum.
GO vs. CL: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Grocery Outlet Holding Corp. (GO) or Colgate-Palmolive (CL). But which of these two stocks offers value investors a better bang for their buck right now?
CL Q3 Earnings Top Estimates, Favorable Currency Aids Organic Sales
Colgate's Q3 earnings beat estimates as pricing gains and favorable currency lift organic sales y/y despite soft volume trends.
Colgate-Palmolive (CL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) Surpasses Q3 Earnings Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.91 per share a year ago.
Colgate-Palmolive Sales Rise as Higher Prices Offset Lower Volumes
Colgate-Palmolive said sales rose in the third quarter, as higher prices offset a decline in volumes.
Colgate's Pre-Q3 Earnings: Will Pricing Actions Offset Cost Headwinds?
CL's Q3 results are likely to reveal how pricing strength and productivity gains help offset inflation, currency pressures and regional softness.
Colgate-Palmolive: 2 Reasons Why The Share Price Drop Has Gone Too Far (Upgrade)
Colgate-Palmolive stock has fallen by nearly 20% over the past year, and this is raising questions regarding market expectations. It seems that the market is pricing in an adverse scenario for margins that is highly unlikely. The current dividend yield does not seem to suggest that CL is undervalued, but there are indications of more notable dividend hikes in the future.
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
